Media & Events

Keep up-to-date on the latest media coverage and events for IceCure Medical.

Our Press Releases >

Filter by:

News

November 19, 2020

Breast Cancer Awareness Month: How Care Has Transformed In 2020

During Breast Cancer Awareness Month, IceCure’s VP of Business Development and Global Marketing, Tlalit Bussi Tel Tzure, was featured in a Forbes Business Development Council Article entitled “Breast Cancer Awareness Month: How Care Has Transformed in 2020.” The article shares

News

August 10, 2020

IceCure shares first published results using the Prosense cryoablation system in kidney cancer

“None of the treated tumor lesions demonstrated contrast enhancement or growth on follow up imaging indicating a 100% oncologic success.” The full research was published in the Journal of Molecular and Clinical Medicine and conducted by Bnai Zion Medical Center

News

July 20, 2020

COVID-19 Pandemic: Now is the Time to Embrace Healthcare Innovation by Tlalit Bussi

In this article, IceCure’s VP Business Development and Marketing, Tlalit Bussi Tel-Tzure’s discusses healthcare innovation in the time of COVID-19. The healthcare landscape has forever changed – are you ready? Read the full article here!

News

May 26, 2020

ICECURE’S PROSENSE® TUMOR FREEZING PRODUCT APPROVED FOR MARKET IN SOUTH AFRICA

Following IceCure’s accelerating global expansion, the company has received regulatory approval for the treatment of benign and cancerous tumors in many indications including for the breast, lung, bone and kidney. Through their new exclusive partner,Tecmed Africa, IceCure’s technology will lead

News

April 28, 2020

IceCure’s Global Expansion Accelerates; Tumor Freezing Product Now Approved for Market in India

New Indian regulatory approval received for its cryoablation technology to destroy tumors in extensive indications, including for breast, lung, bone and kidney cancer. Read more.